Literature DB >> 212449

Conjunctivitis due to adenovirus type 19.

J W Taylor, J W Chandler, M K Cooney.   

Abstract

An outbreak of unusual conjunctivitis occurred in Seattle in the summer of 1974. We found evidence of adenovirus type 19 (Ad19) infection in 28 of 42 (67%) referred cases from whom specimens for virus isolation and/or serology were obtained. Virus was isolated from conjunctiva, throats, and/or stools, often in week 2 of illness. Ad19-related cases more frequently had severe ocular pathology, transient visual impairment, and active disease for longer than a week. Secondary illnesses were more frequent in relation to Ad19 infection (26%) than to conjunctivitis of other etiology (5%, P less than 0.05). Persons with Ad19 infection commonly experienced sore throats without coughs or fevers. No common source of infection was identified in the outbreak, and illness was unrelated to occupation, residence, or family characteristics. A 3- to 8-day incubation period was suggested by two related cases.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 212449      PMCID: PMC275188          DOI: 10.1128/jcm.8.2.209-213.1978

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Letter: Adenovirus 19, a cause of epidemic keratoconjunctivitis, not acute hemorrhagic conjunctivitis.

Authors:  C R Dawson; D O'Day; D Vastine
Journal:  N Engl J Med       Date:  1975-07-03       Impact factor: 91.245

2.  Letter: Acute hemorrhagic conjunctivitis associated with adenovirus Type 19.

Authors:  J W Taylor; J W Chandler; M K Cooney
Journal:  N Engl J Med       Date:  1975-05-01       Impact factor: 91.245

3.  Epidemic keratoconjunctivitis due to adenovirus type 19.

Authors:  R P Burns; M H Potter
Journal:  Trans Am Ophthalmol Soc       Date:  1975

4.  Adenovirus type 19 keratoconjunctivitis in Canada.

Authors:  W B Jackson; P L Davis; V Groh; R Champlin
Journal:  Can J Ophthalmol       Date:  1975-07       Impact factor: 1.882

5.  Letter: Adenovirus type 19 keratoconjunctivitis.

Authors:  J C Hierholzer; B Guyer; D O'Day; W Schaffner
Journal:  N Engl J Med       Date:  1974-06-20       Impact factor: 91.245

6.  Adenovirus type 3 epidemic associated with intermittent chlorination of a swimming pool.

Authors:  H M Foy; M K Cooney; J B Hatlen
Journal:  Arch Environ Health       Date:  1968-11

7.  Epidemiology of group II adenoviruses.

Authors:  D Jung; R Wigand
Journal:  Am J Epidemiol       Date:  1967-03       Impact factor: 4.897

Review 8.  Clinical and laboratory evaluation of epidemic keratoconjunctivitis due to adenovirus types 8 and 19.

Authors:  D M O'Day; B Guyer; J C Hierholzer
Journal:  Am J Ophthalmol       Date:  1976-02       Impact factor: 5.258

9.  Epidemic keratoconjunctivitis: a community outbreak of mixed adenovirus type 8 and type 19 infection.

Authors:  B Guyer; D M O'Day; J C Hierholzer; W Schaffner
Journal:  J Infect Dis       Date:  1975-08       Impact factor: 5.226

10.  Cross relationships among 37 rhinoviruses demonstrated by virus neutralization with potent monotypic rabbit antisera.

Authors:  M K Cooney; G E Kenny; R Tam; J P Fox
Journal:  Infect Immun       Date:  1973-03       Impact factor: 3.441

View more
  3 in total

1.  Restriction endonucleases in identification of a genome type of adenovirus 19 associated with keratoconjunctivitis.

Authors:  G Wadell; J C de Jong
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

2.  Clinical and aetiological study of adenoviral conjunctivitis, with special reference to adenovirus types 4 and 19 infections.

Authors:  K Aoki; M Kato; H Ohtsuka; K Ishii; N Nakazono; H Sawada
Journal:  Br J Ophthalmol       Date:  1982-12       Impact factor: 4.638

3.  The change of etiological agents and clinical signs of epidemic viral conjunctivitis over an 18-year period in southern Taiwan.

Authors:  Cheng-Hsien Chang; Kuei-Hsiang Lin; Min-Muh Sheu; Wen-Loong Huang; Huei-Zu Wang; Chen-Wu Chen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-05-27       Impact factor: 3.117

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.